SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298895
Filing Date
2022-12-06
Accepted
2022-12-06 07:37:08
Documents
14
Period of Report
2022-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407010d8k.htm   iXBRL 8-K 34428
2 EX-99.1 d407010dex991.htm EX-99.1 11176
6 GRAPHIC g407010g1205125705073.jpg GRAPHIC 3313
  Complete submission text file 0001193125-22-298895.txt   175865

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20221205.xsd EX-101.SCH 2832
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20221205_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20221205_pre.xml EX-101.PRE 10800
8 EXTRACTED XBRL INSTANCE DOCUMENT d407010d8k_htm.xml XML 3230
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 221446707
SIC: 2834 Pharmaceutical Preparations